Your browser doesn't support javascript.
loading
Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11).
Kim, Ji-Yeon; Park, Seri; Im, Seock-Ah; Kim, Sung-Bae; Sohn, Joohyuk; Lee, Keun Seok; Chae, Yee Soo; Lee, Ki Hyeong; Kim, Jee Hyun; Im, Young-Hyuck; Kim, Tae-Yong; Lee, Kyung-Hun; Ahn, Jin-Hee; Kim, Gun Min; Park, In Hae; Lee, Soo Jung; Han, Hye Sook; Kim, Se Hyun; Jung, Kyung Hae; Park, Yeon Hee.
Afiliación
  • Kim JY; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.
  • Park S; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, 06351, South Korea.
  • Im SA; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, College of Medicine, Seoul National University, Seoul, 03080, South Korea.
  • Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
  • Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 03722, South Korea.
  • Lee KS; Center for Breast Cancer, National Cancer Center, Goyang, 10408, South Korea.
  • Chae YS; Department of Internal Medicine, Kyungpook National University Hospital, Daegu, 41944, South Korea.
  • Lee KH; Deparment of Internal Medicine, Chungbuk National University Hospital, Cheongju, 28644, South Korea.
  • Kim JH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620, South Korea.
  • Im YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.
  • Kim TY; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, College of Medicine, Seoul National University, Seoul, 03080, South Korea.
  • Lee KH; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, College of Medicine, Seoul National University, Seoul, 03080, South Korea.
  • Ahn JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
  • Kim GM; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 03722, South Korea.
  • Park IH; Center for Breast Cancer, National Cancer Center, Goyang, 10408, South Korea.
  • Lee SJ; Department of Internal Medicine, Kyungpook National University Hospital, Daegu, 41944, South Korea.
  • Han HS; Deparment of Internal Medicine, Chungbuk National University Hospital, Cheongju, 28644, South Korea.
  • Kim SH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 13620, South Korea.
  • Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea. khjung@amc.seoul.kr.
  • Park YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea. yhparkhmo@skku.edu.
Cancer Commun (Lond) ; 39(1): 29, 2019 05 28.
Article en En | MEDLINE | ID: mdl-31138332
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Desoxicitidina / Furanos / Cetonas Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Commun (Lond) Año: 2019 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Desoxicitidina / Furanos / Cetonas Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Female / Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Commun (Lond) Año: 2019 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos